Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Median Technologies SA (ALMDT) Ordinary Shares EUR0.05

Sell:€5.88 Buy:€5.90 Change: €0.06 (1.01%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€5.88
Buy:€5.90
Change: €0.06 (1.01%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€5.88
Buy:€5.90
Change: €0.06 (1.01%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Median Technologies SA is a France-based company that publishes software for the diagnosis and monitoring of cancer patients. The Company develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The Company operates one subsidiary, Median Technologies Inc, based in the United States.

Contact details

Address:
Les Deux Arcs B, 1800 route des Cretes
VALBONNE
06560
France
Telephone:
+33 (4) 93333777
Website:
www.mediantechnologies.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ALMDT
ISIN:
FR0011049824
Market cap:
€71.90 million
Shares in issue:
12.08 million
Sector:
Health Care Technology
Exchange:
Euronext Paris
Country:
France
Currency:
Euro
Indices:
n/a

Key personnel

  • Oran Muduroglu
    Chairman of the Board
  • Fredrik Brag
    Chief Executive Officer
  • Bernard Reymann
    Chief Financial Officer
  • Jeanne Hecht
    Chief Operating Officer, Director
  • Gerard Milhiet
    Executive Vice President, Director
  • Nohza Boujemaa
    Chief Science and Innovation Officer
  • Michael Auffret
    Vice President of Product Management & Regulatory
  • Nicholas Campbell
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.